154 related articles for article (PubMed ID: 2434506)
1. Antibody binding to the beta-subunit of deglycosylated chorionic gonadotropin converts the antagonist to an agonist.
Rebois RV; Liss MT
J Biol Chem; 1987 Mar; 262(8):3891-6. PubMed ID: 2434506
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against human chorionic gonadotropin convert the deglycosylated hormone from an antagonist to an agonist.
Rebois RV; Fishman PH
J Biol Chem; 1984 Jul; 259(13):8087-90. PubMed ID: 6203902
[TBL] [Abstract][Full Text] [Related]
3. Deglycosylated human chorionic gonadotropin. An antagonist to desensitization and down-regulation of the gonadotropin receptor-adenylate cyclase system.
Rebois RV; Fishman PH
J Biol Chem; 1983 Nov; 258(21):12775-8. PubMed ID: 6313676
[TBL] [Abstract][Full Text] [Related]
4. Hydrodynamic properties of the gonadotropin receptor from a murine Leydig tumor cell line are altered by desensitization.
Rebois RV; Bradley RM; Titlow CC
Biochemistry; 1987 Oct; 26(20):6422-8. PubMed ID: 3427017
[TBL] [Abstract][Full Text] [Related]
5. Is deglycosylated human chorionic gonadotropin an antagonist to human chorionic gonadotropin? Characterization of deglycosylated human chorionic gonadotropin action in two testicular interstitial cell fractions.
Browne ES; Flasch MV; Sairam MR; Bhalla VK
Biochim Biophys Acta; 1990 Mar; 1033(3):226-34. PubMed ID: 2156567
[TBL] [Abstract][Full Text] [Related]
6. Conformation of the beta subunit of deglycosylated human chorionic gonadotropin in the interaction at receptor sites.
Hattori M; Hachisu T; Shimohigashi Y; Wakabayashi K
Mol Cell Endocrinol; 1988 May; 57(1-2):17-23. PubMed ID: 3396756
[TBL] [Abstract][Full Text] [Related]
7. Reversal of the antagonism of deglycosylated human chorionic gonadotropin by aggregation with wheat germ agglutinin.
Hattori M; Shimohigashi Y; Wakabayashi K
Mol Cell Endocrinol; 1989 Oct; 66(2):207-14. PubMed ID: 2558927
[TBL] [Abstract][Full Text] [Related]
8. Deglycosylated human chorionic gonadotropin (hCG) antagonizes hCG stimulation of 3',5'-cyclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors.
Dunkel L; Jia XC; Nishimori K; Boime I; Hsueh AJ
Endocrinology; 1993 Feb; 132(2):763-9. PubMed ID: 8381073
[TBL] [Abstract][Full Text] [Related]
9. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine.
Dirnhofer S; Klieber R; De Leeuw R; Bidart JM; Merz WE; Wick G; Berger P
FASEB J; 1993 Nov; 7(14):1381-5. PubMed ID: 7693535
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of the receptor-bound agonistic form of human chorionic gonadotropin (hCG) in comparison to the antagonistic form (deglycosylated hCG).
Schwartz S; Krude H; Merz WE; Lottersberger C; Wick G; Berger P
Biochem Biophys Res Commun; 1991 Jul; 178(2):699-706. PubMed ID: 1713453
[TBL] [Abstract][Full Text] [Related]
11. Polyclonal antibodies against the polypeptide and carbohydrate epitopes of recombinant human choriogonadotropin beta-subunit.
Chen W; Bahl OP
Mol Cell Endocrinol; 1992 Jul; 86(1-2):57-66. PubMed ID: 1380928
[TBL] [Abstract][Full Text] [Related]
12. Complete dissociation of gonadotropin receptor binding and signal transduction in mouse Leydig tumour cells. Obligatory role of glycosylation in hormone action.
Sairam MR
Biochem J; 1990 Feb; 265(3):667-74. PubMed ID: 2306206
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate modifications transform human chorionic gonadotropin into a potent stimulator of adenosine 3',5'-monophosphate and growth responses in FRTL-5 thyroid cells.
Hoermann R; Keutmann HT; Amir SM
Endocrinology; 1991 Feb; 128(2):1129-35. PubMed ID: 1846577
[TBL] [Abstract][Full Text] [Related]
14. Establishment of gonadotropin-responsive murine leydig tumor cell line.
Rebois RV
J Cell Biol; 1982 Jul; 94(1):70-6. PubMed ID: 6288740
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the biological and immunological properties of glycosylation deficient human chorionic gonadotropin variants produced by site directed mutagenesis and chemical deglycosylation.
Sairam MR; Jiang LG
Mol Cell Endocrinol; 1992 Jun; 85(3):227-35. PubMed ID: 1634018
[TBL] [Abstract][Full Text] [Related]
16. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.
Hoermann R; Amir SM; Nomura T; Ingbar SH
Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487
[TBL] [Abstract][Full Text] [Related]
17. Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG.
Krichevsky A; Birken S; O'Connor J; Acevedo HF; Bikel K; Lustbader J; Hartree A; Canfield RE
Endocrinology; 1994 Mar; 134(3):1139-45. PubMed ID: 7509735
[TBL] [Abstract][Full Text] [Related]
18. Preferential masking by the receptor of immunoreactive sites on the alpha subunit of human choriogonadotropin.
Milius RP; Midgley AR; Birken S
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7375-9. PubMed ID: 6200873
[TBL] [Abstract][Full Text] [Related]
19. Photoaffinity labeling of the gonadotropin receptor with native, asialo, and deglycosylated choriogonadotropin.
Nishimura R; Raymond MJ; Ji I; Rebois RV; Ji TH
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6327-31. PubMed ID: 3018725
[TBL] [Abstract][Full Text] [Related]
20. Topographical differences in human choriogonadotropin antagonist as revealed by monoclonal antibodies.
Jiang LG; Sairam MR
Mol Cell Endocrinol; 1994 Mar; 99(2):201-10. PubMed ID: 8206328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
